Impax US Small Cap Strategy Composite (S:0P0001B2SM)
52.98
-2.41
(-4.35%)
USD |
Sep 30 2026
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of October 25, 2026.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Victory Capital Holdings, Inc. | 4.96% | 107.60 | 0.20% |
|
Crinetics Pharmaceuticals Inc
|
3.88% | -- | -- |
| Pinnacle Financial Partners, Inc. | 3.47% | 100.35 | -0.11% |
| Agree Realty Corp. | 3.04% | 66.70 | -0.55% |
| Acadian Asset Management, Inc. | 2.97% | 92.35 | -0.47% |
| Eastern Bankshares, Inc. | 2.94% | 22.40 | 1.31% |
| SI-BONE, Inc. | 2.85% | 21.48 | -0.37% |
| Neurocrine Biosciences, Inc. | 2.59% | 142.70 | -0.41% |
| Ligand Pharmaceuticals, Inc. | 2.24% | 303.53 | -1.39% |
| Zebra Technologies Corp. | 2.14% | 386.45 | 0.60% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | -- |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | -- |
| Socially Responsible Fund | -- |